Meridian Bioscience to Participate in the 2022 H. C. Wainwright Bioconnect Virtual Conference

Rhea-AI Summary

Meridian Bioscience, a provider of diagnostic testing solutions, will participate in the 2022 H. C. Wainwright Bioconnect Virtual Conference. CEO Jack Kenny is set to pre-record a presentation available on January 10, 2022. The webcast can be accessed via Meridian's Investor Relations website, where it will remain available for 90 days. Meridian focuses on innovative diagnostics for various applications and serves clients in over 70 countries. The company's shares trade on NASDAQ under the symbol VIVO.

CINCINNATI, Jan. 4, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO) a provider of diagnostic testing solutions and life science raw materials, announced today its participation in the 2022 H. C. Wainwright Bioconnect Virtual Conference.  Jack Kenny, Chief Executive Officer, will pre-record a presentation that will be available on January 10, 2022.

Webcast links to Meridian's presentation will be available in the Events & Presentations section of the Company's Investor Relations website at https://investor.meridianbioscience.com/.  The fireside chat will be available for 90 days.

For additional information on the H. C. Wainwright Bioconnect 2022 Virtual Conference, please visit www.hcwevents.com/bioconnect. 

About Meridian Bioscience, Inc.
Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products. We are dedicated to developing and delivering better solutions that give answers with speed, accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, we provide critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, we provide diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. We build relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world.

Meridian's shares are traded on the NASDAQ Global Select Market, symbol VIVO. Meridian's website address is www.meridianbioscience.com.

Contact:
Charlie Wood
Vice President – Investor Relations
Meridian Bioscience, Inc.
Phone:  +1 513.271.3700
Email: mbi@meridianbioscience.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/meridian-bioscience-to-participate-in-the-2022-h-c-wainwright-bioconnect-virtual-conference-301453854.html

SOURCE Meridian Bioscience, Inc.

FAQ

When will Meridian Bioscience present at the H. C. Wainwright Bioconnect Virtual Conference?

Meridian Bioscience will present at the conference on January 10, 2022.

Where can I watch Meridian Bioscience's presentation from the conference?

The presentation can be viewed on Meridian's Investor Relations website.

How long will the webcast of Meridian's presentation be available?

The webcast will be available for 90 days after the presentation.

What is the stock symbol for Meridian Bioscience?

The stock symbol for Meridian Bioscience is VIVO.

What type of company is Meridian Bioscience?

Meridian Bioscience is a life science company that develops diagnostic testing solutions and life science raw materials.